A former Labour Party press officer has launched the first independent public affairs agency dedicated exclusively to healthcare.Camden-based Advocate's managing …
NicOx is to develop a new statin treatment using its special in-house technology which, according to the company, could make …
Santhera Pharmaceuticals is collaborating with Finnish biotech company Juvantia Pharma to develop a treatment for dyskinesia, the distressing involuntary movements …
Health think-tank the King's Fund has called for a fundamental re-examination in the way NHS cancer services are provided in …
The government has signed a deal with logistics company DHL to take over the purchase of essential items to the …
Sativex, the cannabis-derived product developed by GW Pharmaceuticals could be finally set for approval after a delay of around two …
A US district court has granted an injunction to stop sales of the generic version of blood-thinner Plavix, the world's …
AstraZeneca is to work with a spin-off company set up by Cancer Research UK to research and develop new treatments …
More than a quarter of older patients in the UK are missing out on medicines, either because they simply fail …
Following grim warnings that more than 12 million adults and one million children in England will be obese in less …
According to a recent survey, four out of every 10 employees are thinking about changing their job in the next …
The changing NHS customerAs NHS customers change, CSOs are having to adapt and forge new partnerships, and develop new skills.
Over the years, the numbers of women taking up positions of authority in the pharmaceutical industry has grown considerably, and …
A new survey of the UK pharmaceutical industry suggests the sector is failing to hire the best talent because of …
More drugs are to be switched to NICE's new fast-track appraisal system, with the government reaffirming its pledge to end …
Novartis' new treatment for the rare and difficult to treat condition of transfusional iron overload has been approved in the …
Here's a challenge: find someone with PhD-level scientific knowledge, a strong management track record and entrepreneurial flair. If there are …
GlaxoSmithKline has formed an alliance with Californian biotech company ChemoCentryx through its innovative drug development partnering unit.A licensing deal has …
The blockbuster non-Hodgkin's lymphoma treatment MabThera could offer a new treatment option for people with multiple sclerosis according to new …
Newbury and Community PCT has lost its appeal against NICE's recommendation for cancer drug Herceptin, finally ending the battle over …